Cargando…
Light‐Controllable Binary Switch Activation of CAR T Cells
Major challenges to chimeric antigen receptor (CAR) T cell therapies include uncontrolled immune activity, off‐tumor toxicities and tumor heterogeneity. To overcome these challenges, we engineered CARs directed against small molecules. By conjugating the same small molecule to distinct tumor‐targeti...
Autores principales: | Kobayashi, Aya, Nobili, Alberto, Neier, Steven C., Sadiki, Amissi, Distel, Robert, Zhou, Zhaohui Sunny, Novina, Carl D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304291/ https://www.ncbi.nlm.nih.gov/pubmed/35146940 http://dx.doi.org/10.1002/cmdc.202100722 |
Ejemplares similares
-
Clutch Control: Changing the Speed and Direction of CAR-T Cell Therapy
por: Nobili, Alberto, et al.
Publicado: (2022) -
Site-specific conjugation of native antibody
por: Sadiki, Amissi, et al.
Publicado: (2020) -
RATA: A method for high-throughput identification of RNA bound transcription factors
por: Schmidt, Karyn, et al.
Publicado: (2017) -
The lncRNA SLNCR Recruits the Androgen Receptor to EGR1-Bound Genes in Melanoma and Inhibits Expression of Tumor Suppressor p21
por: Schmidt, Karyn, et al.
Publicado: (2019) -
Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs
por: Moghanloo, Ehsan, et al.
Publicado: (2021)